Saturday 17 October 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024. In the quarter to June 2026, revenue grew 19.9%, EPS fell 81.6%, free cash flow fell 20.3% and total debt rose 602.2%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

54.68 1.37 −2.44%

Follow BMRN

Alert me

Market cap: $10.9B
P/E: 144×
Fwd P/E: 16.1×
Dividend yield: —
F-score: 5/9
Altman Z: 5.67
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	9.07%	5.94%	4.48%	1.18%
Piotroski F-Score Full definition →		8	5	4	3
ROA Full definition →		7.20%	4.79%	3.42%	0.76%
ROIC Full definition →		7.43%	5.00%	3.64%	0.97%
Return on Tangible Assets Full definition →		12.71%	8.41%	5.63%	2.21%
Average Days of Receivables Full definition →		93.23	102.91	101.76	113.69
Free Cash Flow per Share Full definition →		4.30	3.74	3.98	3.75
Free Cash Flow Full definition →		825.79	717.02	767.06	724.81
Capital Expenditures Full definition →		(88.18)	(110.97)	(107.19)	(132.28)
Other line items
Cash ROIC Full definition →		10.16%	8.70%	7.78%	6.37%
Accounts Receivable Turnover Full definition →		3.95	4.11	3.95	3.55
Accounts Payable Turnover Full definition →		0.76	1.05	1.07	0.96
Inventory Turnover Full definition →		0.45	0.57	0.60	0.52
Average Days of Payables Full definition →		504.32	386.16	380.48	451.23
Days of Inventory on Hand Full definition →		873.02	660.81	610.77	799.69
Tax Rate Full definition →		(0.23)	(0.28)	(0.30)	(0.51)
Research and Development Expense of Revenue Full definition →		29.19%	28.62%	29.05%	28.99%
Selling, General and Administrative Expense of Revenue Full definition →		31.46%	35.79%	37.17%	40.17%
Share Based Compensation of Revenue Full definition →		6.03%	5.63%	5.77%	6.32%
Interest Coverage Full definition →		57.53	37.57	13.71	1.79
Operating CF/Net income Full definition →		1.76	2.37	3.25	11.75
Depreciation/Fixed assets Full definition →		0.07	0.08	0.07	0.15
Capex/Depreciation Full definition →		(1.14)	(1.48)	(1.53)	(0.89)
Revenue per Share Full definition →		16.11	16.80	16.84	17.61
Operating CF per Share Full definition →		4.76	4.32	4.54	4.43
Capex per Share Full definition →		(0.46)	(0.58)	(0.56)	(0.68)
Capex to Sales Full definition →		0.03	0.03	0.03	0.04

Fold the line items

Columns are period end dates

Stockrow Weekly